Drug class in one race
Endothelin A receptor drugs for Chronic Kidney Disease
2 tracked Endothelin A receptor drugs in the Chronic Kidney Disease race. The class explanation lives on the Endothelin A receptor page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.
1 approved / phase 41 Phase 2
Head-to-head evidence: Atrasentan vs Zibotentan